chr2-121530887-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting
The NM_001395891.1(CLASP1):c.196-562G>C variant causes a intron change. The variant allele was found at a frequency of 0.0000231 in 692,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001395891.1 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLASP1 | NM_001395891.1 | c.196-562G>C | intron_variant | Intron 2 of 40 | ENST00000696935.1 | NP_001382820.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLASP1 | ENST00000696935.1 | c.196-562G>C | intron_variant | Intron 2 of 40 | NM_001395891.1 | ENSP00000512981.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000154 AC: 2AN: 129556Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 70760
GnomAD4 exome AF: 0.0000259 AC: 14AN: 540686Hom.: 0 Cov.: 0 AF XY: 0.0000240 AC XY: 7AN XY: 291572
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
Roifman syndrome Pathogenic:1
The heterozygous n.7C>G variant in RNU4ATAC was identified by our study, in the compound heterozygous state with a pathogenic variant (ClinVar Variation ID: 1403727), in three siblings with microcephaly, retinal anomalies, motor delay, bronchiectasis, and multiple endocrine anomalies. Familial exome analysis revealed that this variant was in trans with a pathogenic variant (ClinVar Variation ID: 1403727). The n.7C>G variant in RNU4ATAC has not been previously reported in individuals with Roifman syndrome but has been identified in 0.0065% (1/15286) of Latino/Admixed American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs370715569). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant segregated with disease in the three affected individuals in the family identified by our study. Two different nucleotide changes at this site that have the same predicted impact have been reported pathogenic or likely pathogenic in the literature and/or in ClinVar, n.7G>A (PMID: 26522830, PMID: 32628740, Variation ID: 218086) and n.7G>T (Variation ID: 692040) have been reported pathogenic or likely pathogenic in the literature and in ClinVar. Multiple variants in the same region as n.7C>G have been reported in association with disease in the literature and the n.7C>G variant is located in a region of RNU4ATAC that is essential to its spliceosome activity, suggesting that this variant is in a key functional domain and slightly supports pathogenicity (PMID: 32628740). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive Roifman syndrome. ACMG/AMP Criteria applied: PS1_Supporting, PM3, PM1_Supporting, PM2_Supporting, PP1, PP3 (Richards 2015). -
not provided Uncertain:1
This variant occurs in the RNU4ATAC gene, which encodes an RNA molecule that does not result in a protein product. This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with RNU4ATAC-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts the n.8C nucleotide in the RNU4ATAC gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 26522830, 32628740; Invitae). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at